|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Imcor Pharmaceutical Co (ICRP.PK)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
IMCOR PHARMACEUTICAL CO: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-04-14- -2004-04-19 Purchase(A) |
2004-07-02 6:28 pm | IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 37,273,287 | $0.4 | $14,909,315 | 43,754,769 (Indirect) |
View |
| 2004-04-14- -2004-04-19 Purchase(A) |
2004-07-02 6:27 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 36,916,285 | $0.4 | $14,766,514 | 43,333,382 (Direct) |
View |
| 2004-04-14- -2004-04-19 Purchase | 2004-06-17 5:48 pm | IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 19,827,685 | $0.75 | $14,870,764 | 26,309,167 (Indirect) |
View |
| 2004-04-14- -2004-04-19 Purchase |
2004-06-17 5:47 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 19,648,394 | $0.75 | $14,736,296 | 26,065,491 (Direct) | View |
| 2004-04-20 Sale | 2004-04-21 5:26 pm | IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 11,300 | $0.9174 | $10,367 | 2,133,728 (Indirect) |
View |
| 2004-04-15 Sale |
2004-04-19 11:51 am | IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 16,430 | $0.9471 | $15,561 | 2,145,028 (Indirect) |
View |
| 2004-04-14 Sale |
2004-04-15 5:13 pm | IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 96,900 | $1.158 | $112,171 | 2,161,458 (Indirect) | View |
| 2004-01-27 Sale | 2004-01-29 4:44 pm | PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 56,325 | $1.11 | $62,521 | 2,258,358 (Indirect) | View |
| 2004-01-26 Sale | 2004-01-27 1:36 pm |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 13,375 | $1.23 | $16,451 | 2,314,683 (Indirect) | View |
| 2004-01-21 Sale | 2004-01-22 5:26 pm |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 11,300 | $1.23 | $13,899 | 2,328,058 (Indirect) | View |
| 2004-01-08- -2004-01-09 Sale | 2004-01-14 5:09 pm | PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 109,000 | $1.468 | $160,018 | 2,339,358 (Indirect) |
View |
| 2003-08-01- -2003-09-02 Purchase |
2004-01-14 5:08 pm |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 109,225 | $1 | $109,225 | 2,448,358 (Indirect) | View |
(A) Indicate amendment filing.
Other purchase or sale (not a common stock or no ticker symbol):
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2004-04-14- -2004-04-19 Sale(A) | 2004-07-02 6:28 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 12,701,315 | $0.4 | $5,080,526 | 0 (Indirect) | View |
| 2004-04-14- -2004-04-19 Sale(A) | 2004-07-02 6:27 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 12,588,368 | $0.4 | $5,035,347 | 0 (Direct) |
View |
| 2004-04-14- -2004-04-19 Sale |
2004-06-17 5:48 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 12,670,763 | $0.75 | $9,503,073 | 0 (Indirect) | View |
| 2004-04-14- -2004-04-19 Sale | 2004-06-17 5:47 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 12,558,149 | $0.75 | $9,418,612 | 0 (Direct) |
View |
(A) Indicate amendment filing.
Other transactions:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount | Shares Ownership |
Filing |
| 2005-01-10 Option Award |
2005-02-17 2:33 pm | IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN (Director 10% owner) | 50,286 | $0.35 | $17,600 | 45,011,788 (Indirect) | View |
| 2005-01-10 Option Award | 2005-02-17 2:33 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 49,786 | $0.35 | $17,425 | 44,564,652 (Direct) |
View |
| 2004-03-15 Gift | 2004-03-17 12:21 pm |
IMCOR PHARMACEUTICAL CO | ICPH | LEVINE STUART P (10% owner) | 4,000 | $0 | $0 | 475,105 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date | Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2004-10-01 Option Award | 2005-03-22 11:41 am | N/A 2014-10-01 | IMCOR PHARMACEUTICAL CO | ICRP.PK | DEPTULA-HICKS DARLENE M (Director) | 3,000 | $2.8 | 3,000 (Direct) |
View |
| 2004-01-01 Option Award |
2005-03-08 2:31 pm |
2004-04-01 2014-01-01 | IMCOR PHARMACEUTICAL CO | ICRP.PK | WATSON ALAN (Director) | 500 | $36.2 | 4,500 (Direct) |
View |
| 2005-03-04 Option Award | 2005-03-08 2:20 pm |
2005-03-04 2015-03-04 |
IMCOR PHARMACEUTICAL CO | ICRP.PK | GALLAGHER BRIAN M (Director) | 95,000 | $8 | 100,000 (Direct) | View |
| 2004-06-30 Option Award | 2005-03-08 10:51 am | N/A 2014-06-30 | IMCOR PHARMACEUTICAL CO | ICRP.PK | WILLIAMS TAFFY J (CEO and President Director) | 201,421 | $8 | 368,094 (Direct) | View |
| 2004-04-14 Purchase | 2004-07-02 6:28 pm |
2004-04-14 2009-04-14 | IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 2,750,001 | $0.5 | 2,750,001 (Indirect) | View |
| 2004-04-14 Purchase | 2004-07-02 6:27 pm |
2004-04-14 2009-04-14 |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 2,722,683 | $0.5 | 2,722,683 (Direct) |
View |
| 2004-04-14 Purchase |
2004-06-17 5:48 pm |
2004-04-14 2009-04-14 | IMCOR PHARMACEUTICAL CO | ICPHC | FLEMING JONATHAN OBP MANAGEMENT IV LP (Director 10% owner) | 1,466,668 | $1 | 1,466,668 (Indirect) | View |
| 2004-04-14 Purchase | 2004-06-17 5:47 pm | 2004-04-14 2009-04-14 |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 1,452,098 | $1 | 1,452,098 (Direct) | View |
| 2004-04-20 Purchase | 2004-04-21 5:26 pm |
N/A 2005-06-18 |
IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 11,300 | $1 | 1,611,989 (Indirect) |
View |
| 2004-04-15 Purchase | 2004-04-19 11:51 am | N/A 2005-06-18 | IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 16,430 | $1 | 1,623,289 (Indirect) |
View |
| 2004-04-14 Purchase | 2004-04-15 5:13 pm |
N/A 2005-06-18 |
IMCOR PHARMACEUTICAL CO | ICPHC | XMARK ASSET MANAGEMENT LLC (10% owner) | 96,900 | $1 | 1,639,719 (Indirect) | View |
| 2004-02-16 Option Award | 2004-04-13 3:14 pm |
N/A 2014-02-16 |
IMCOR PHARMACEUTICAL CO | ICPH | MCPHEE WILLIAM D (Director) | 60,000 | $2.2 | 60,000 (Direct) | View |
| 2004-02-16 Option Award |
2004-02-17 12:24 pm | N/A 2014-02-16 | IMCOR PHARMACEUTICAL CO | ICPH | DEAN RICHARD T (Director) | 60,000 | $1.3 | 60,000 (Direct) | View |
| 2004-02-13 Option Award |
2004-02-17 09:33 am | N/A 2014-02-13 | IMCOR PHARMACEUTICAL CO | ICPH | WATSON ALAN (Director) | 60,000 | $2.2 | 80,000 (Direct) | View |
| 2004-01-27 Purchase |
2004-01-29 4:44 pm |
N/A 2005-06-18 | PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 56,325 | $1 | 1,736,619 (Indirect) |
View |
| 2004-01-26 Purchase | 2004-01-27 1:36 pm | N/A 2005-06-18 |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 13,375 | $1 | 1,792,944 (Indirect) |
View |
| 2004-01-21 Purchase | 2004-01-22 5:26 pm | N/A 2005-06-18 |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 11,300 | $1 | 1,806,319 (Indirect) |
View |
| 2004-01-14 Other | 2004-01-15 1:50 pm | 2003-11-12 2012-10-31 |
PHOTOGEN TECHNOLOGIES INC | PHGN | WILLIAMS TAFFY J (CEO, President Director) | 1,233,450 | $1.08 | 2,283,450 (Direct) | View |
| 2004-01-14 Option Award | 2004-01-15 1:50 pm | N/A 2014-01-14 |
PHOTOGEN TECHNOLOGIES INC | PHGN | WILLIAMS TAFFY J (CEO, President Director) | 1,050,000 | $1.08 | 3,333,450 (Direct) |
View |
| 2004-01-08 Purchase |
2004-01-14 5:09 pm |
N/A 2005-06-18 | PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 82,600 | $1 | 1,844,019 (Indirect) | View |
| 2004-01-09 Purchase |
2004-01-14 5:09 pm | N/A 2005-06-18 |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 26,400 | $1 | 1,817,619 (Indirect) |
View |
| 2003-08-01 Purchase | 2004-01-14 5:08 pm | N/A 2005-06-18 |
PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 82,977 | $1 | 1,900,371 (Indirect) |
View |
| 2003-09-02 Purchase | 2004-01-14 5:08 pm |
N/A 2005-06-18 | PHOTOGEN TECHNOLOGIES INC | PHGN | XMARK ASSET MANAGEMENT LLC (10% owner) | 26,248 | $1 | 1,926,619 (Indirect) | View |
| 2004-01-14 Option Award | 2004-01-14 11:38 am | 2005-01-14 2014-01-14 |
PHOTOGEN TECHNOLOGIES INC | PHGN | BOVEROUX BROOKS (CFO and Senior VP) | 25,000 | $1.47 | 888,375 (Direct) |
View |
| 2004-01-07 Option Award |
2004-01-09 1:08 pm |
2005-01-07 2014-01-07 | PHOTOGEN TECHNOLOGIES INC | PHGN | DEFRANCO JACK (Senior VP of IMCOR Division) | 40,000 | $1.47 | 210,000 (Direct) | View |
| 2002-11-12 Option Award | 2003-09-26 2:29 pm | 2003-11-12 2012-10-31 | PHOTOGEN TECHNOLOGIES INC | PHGNE | WILLIAMS TAFFY J (CEO, President and Chairman Director) | 1,233,450 | $1.08 | 2,283,450 (Direct) | View |
| 2002-11-12 Option Award |
2003-09-18 3:45 pm | 2004-11-12 2012-10-31 | PHOTOGEN TECHNOLOGIES INC | PHGNE | BOVEROUX BROOKS (CFO and Senior VP) | 550,875 | $1.08 | 863,375 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 05:24:50 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |